托伐普坦(INN，商标是Samsca和Jinarc)是一种水生药物，具有选择性、竞争性加压素受体2拮抗剂的功能，用于治疗与充血性心力衰竭、肝硬化和不适当的抗利尿剂h综合征相关的低钠血症(低血钠水平)奥尔蒙（SIADH）。托伐普坦于2009年5月19日被美国食品和药物管理局(FDA)批准，由大阪制药公司以商品名Samsca销售，在印度由MSN实验室有限公司以商品名Tolsama & Tolvat生产和销售。
2-Methylbenzoyl chloride
Methyl 5-chloro-2-nitrobenzoate
3-Methyl-4-nitrobenzoyl chloride
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
5-Chloro-2-fluorobenzaldehyde
1-(4-Amino-2-methylbenzoyl)-7-chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one
7-Chloro-1-(2-methyl-4-nitrobenzoyl)-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one
Methyl 2-amino-5-chlorobenzoate
N-(4-(7-Chloro-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide
5-Chloro-2-nitrobenzoic acid
Ethyl 4-bromobutyrate
Methyl 7-chloro-5-oxo-1-tosyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylate
Methyl 5-chloro-2-(4-methylphenylsulfonamido)benzoate
Methyl 5-chloro-2-((N-(4-ethoxy-4-oxobutyl)-4-methylphenyl)sulfonamido)benzoate
7-Chloro-1-tosyl-1,2,3,4-tetrahydro-5H-benzo[b]azepin-5-one
Ethenyl 2,2-dimethylpropanoate
